• Mashup Score: 0
    Current Issue : Oncology Times - 8 month(s) ago

    Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!

    Source: journals.lww.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncologyTimes
      OncologyTimes

      New Issue Out Now! The August 20th issue features: The Severity & Significance of the Ongoing #Chemotherapy Shortage, New Data Support Value of ctDNA as a Cancer #Biomarker, and more: https://t.co/uqhfn0pxBF #CancerResearch https://t.co/9Faurb3yPN

  • Mashup Score: 0
    Four Novel Biomarkers May Help Detect Black Patients at Risk of Advanced Prostate Cancer - The ASCO Post - 8 month(s) ago

    Researchers have identified a cell metabolism process found in male patients with West African ancestry who have diabetes and metastatic prostate cancer that could potentially lead to improved testing and treatments for Black patients with both diseases. The findings by Shuck et al were presented at the American Chemical Society Fall 2023 meeting. Black patients are 60% more likely than White patients to be diagnosed with diabetes and twice as likely to die from the disease. The American Cancer Society

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Four Novel Biomarkers May Help Detect Black Patients at Risk of Advanced Prostate Cancer https://t.co/ECOrgjE1YP #pcsm #prostatecancer #oncology #biomarker

  • Mashup Score: 0
    Steering Committee - 9 month(s) ago

    SELECT DISEASE STATE TO EXPLORE To bring key stakeholders (HCPs, pharmaceutical and biotech companies, associations and advocacy groups) together for the common purpose of providing accurate and relevant information to the broader oncology community about the importance of testing and biomarker identification, and how to utilize biomarker status to inform treatment decisions. To emphasize the importance of biomarker testing, comprehensive genomic profiling, and identification of actionable targets across

    Source: www.onclive.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncLive
      OncLive

      A unified effort is needed to improve #biomarker testing and applying testing results in clinical practice. Learn more from the Biomarker Consortium. https://t.co/RW6mhbh5iU #NSCLC https://t.co/ZAfy90hC7C

  • Mashup Score: 1
    Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study - 9 month(s) ago

    , University of Colorado‐School of Public Health, , Department of Biostatistics and Informatics, , Aurora, , CO, , USA, *Correspondence to: Jesse Davidson, MD, Children’s Hospital Colorado, 13123 E 16th Ave, ‐Box 100, Aurora, CO 80045. Email: Congenital heart disease (CHD) is a risk factor for the development of necrotizing enterocolitis (NEC). 1 NEC has an incidence of 3% to 5% in the population with CHD and is associated with a 2‐fold increase in mortality (24.4% versus 11.8% in neonates with CHD

    Source: www.ahajournals.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JAHA_AHA
      JAHA_AHA

      Pilot study from @ChildrensColo demonstrates power of novel low volume #proteomics techniques to safely perform #biomarker discovery in neonates w/ #CHD & necrotizing enterocolitis. #AHAJournals #ResearchLetter @ChildrensCO_Pro @OlinkProteomics @JesseCicu https://t.co/WcTtk70VJU https://t.co/isltoVNWze

Load More